12:00 AM
 | 
Feb 20, 2012
 |  BC Week In Review  |  Company News  |  Deals

Quanterix, Beth Israel Deaconess Medical Center, Forsyth Institute deal

The entities partnered to use Quanterix's Single Molecule Array (SiMoA) technology to validate low abundance biomarkers useful in identifying individuals with active tuberculosis...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >